This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Biogen Inc (BIIB)

NASDAQ: Health Care

Company Profile
Price and Volume
Recent Price 294.25
52 Week High 480.18
52 Week Low 254.00
Avg. Daily Vol. (Mil) 2.89
Beta (3 year) 0.39
Share Related Items
Mkt Cap (Mil) 65,589.24
Shares Out (Mil) 222.90
Float (Mil) 234.98
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 2.80
Current Ratio 3.50
LT Debt/ Equity 0.62
Total Debt / Equity 0.62
Valuation Ratios
Price Earnings 19.20
Price/Sales 7.09
Price/Book 6.20
Price/Cash Flow 15.40
Per Share Data
Earnings 15.31
Sales 41.52
Book Value 47.43
Cash Flow 19.06
Business Summary
Biogen Idec Inc, is a biopharmaceutical company. The Company discovers, develops, manufactures and markets therapies for neurological, autoimmune and hematologic disorders.
General Information
225 Binney Street
Cambridge, MA 02142
Industry : Drugs
Sector: Health Care
Employees: 7550
CEO: Dr. George A. Scangos,Ph
Short Interest
Current Month (Mil) 3.38
Previous Month (Mil) 4.25
Short Interest Ratio (Days) 0.90
Management Effectiveness
Return on Equity 34.50
Return on Assets 17.60
Return on Investments 21.30
Gross Margin 89.20
EBIT Margin 52.70
Profit Margin 39.40

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

Analysts Ratings for BIIB

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 12 12 12 11
Moderate Buy 2 2 2 2
Hold 7 7 8 9
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0

BIIB Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs